Life Science Nation Newsletter  | October 12,  2017  |  Issue 235

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Consulting
Life Science Investor Mandates (Oct. 5  - Oct. 11)
Raises New Medtech Seed Fund
Looks for New Opportunities in Therapeutics, Diagnostics and Medical Devices
to Invest In Healthcare IT Companies
Dedicates $100 Million Fund to US Pharma and Medtech Opportunities
In This Issue
Nature BioEntrepreneur Features LSN: Aligning Needs
LSN Services
Click to see investors that are a fit for your product and stage of development

Click here if you are a service provider and want to see a list of funded life science companies that are a fit for you

Click here if you want to receive free, targeted early stage dealflow for your life science investment firm

Free Copy of LSN's Book

LSN Videos
By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series

Life Science Nation (LSN) and our title sponsors Johnson and Johnson Innovation JLABS, WuXi AppTec and McDermott Will & Emery are excited to bring RESI to NYC for the first time this November.The event has already caught the attention of a wide range of investors. From New York family offices and New Jersey-based pharma to Asia-Pacific funds and major global strategics, RESI will bring a diverse range of early stage life science investors to the rising NYC biotech and medtech hub.

By providing a venue for these global players in the heart of New York's innovation scene, RESI will create dialogue and relationship building, with the goal of eventual capital allocations. If you'd like the opportunity to join these investors for networking, expert advice and one-on-one meetings, register for RESI now.

Confirmed Investors and Strategic Partners

As of October 12th, 2017
By Lucy Parkinson, Director of Research, LSN

On November 15th, RESI will come to New York City for the first time ever. As New York's biotech scene is on the cusp of becoming a major hub, LSN is excited to add RESI as a venue for the city's emerging biotech and medtech companies to meet with hundreds of global investors.

LSN would now like to announce the agenda for RESI NYC. The event will include 24 investor panels and entrepreneur workshops, including new panels focused on New York biotech and Collaborative Virtual Pharma, and the very first RESI panel of Private Equity & Hedge Funds that invest directly in privately held life science companies. Additionally, a legal workshop will be led by our title sponsor, McDermott Will & Emery. RESI NYC will also feature an updated Asia-North America healthcare investment track, with focus sessions on China Pharma Partners and China Medtech Investors. Check out the full content below. If you want to take part, you can register now.

Could China's CFDA Reforms Have a Positive Impact for US Entrepreneurs?
By James Huang, Research Analyst, LSN

On Monday, the China Food and Drug Administration (CFDA) held a press conference to announce a reform to their regulatory review and approval process for medical devices and drugs. The major takeaways from for these policy changes are as follows:
  • Faster drug/device approval process
    • China has suggested that data from overseas clinical trials can be accepted for use in the drug/device approval process.
    • The guidelines also suggested that fast-track approval would be granted to drugs/devices targeting diseases without therapies, key projects identified by the government, and orphan drugs.
China's pharmaceutical market is currently the second largest in the world with growth rates of around 9%. These changes should allow for foreign drug companies to enter that market more easily and as a result, warrants a second look for anyone currently developing new and innovative therapeutics...

QuickFire Challenge
I n honor of the Grand Opening of JLABS @ NYC, Johnson & Johnson Innovation has launched a QuickFire Challenge to award up to four new game-changing early-stage innovation companies with the use of a bench, workstation and access to the JLABS @ NYC community for one year.

This competition will award the person or team(s) who submits the best idea, technology, or solution in the following areas:
  • Consumer healthcare
  • Health technologies
  • Medical devices
  • Therapeutics